According to the report, the global transdermal drug delivery system market was USD 5,837 million in 2018 and is expected to generate around USD 8,127 million by 2025, growing at a CAGR of 4.8% between 2019 and 2025.
New York, NY, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Transdermal Drug Delivery System Market By Type (Transdermal Patches and Transdermal Semisolids), By Application (Pain Management, Hormonal Applications, Central Nervous System Disorders, Cardiovascular Diseases, and Others), and By End-User (Home Care Settings and Hospitals & Clinics): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global transdermal drug delivery system market was USD 5,837 million in 2018 and is expected to generate around USD 8,127 million by 2025, growing at a CAGR of 4.8% between 2019 and 2025.
Transdermal drug delivery systems deliver drugs via the skin to ensure a systemic drug circulation and maintain clinically effective concentrations at a predetermined rate over an estimated timeline. The substantial advancements in the biotechnology industry and improving capabilities of medical practitioners who use drugs at specific locations without causing skin rupture.
Browse through 54 Tables & 21 Figures spread over 120 Pages and in-depth TOC on “Global Transdermal Drug Delivery System Market Size, Share 2018: By Type, Applications, Industry Segments, Analysis and Forecast, 2018–2025”.
Request Free Sample Report of Global Transdermal Drug Delivery System Market @ https://www.zionmarketresearch.com/sample/transdermal-drug-delivery-system-market
The rising occurrences of chronic diseases and various technological developments in healthcare, pharmaceutical, and biotechnology sectors are boosting the transdermal drug delivery system market globally. Various applications of these systems are useful in hormonal disorders, pain management, central nervous system ailments, cardiovascular diseases, which will generate lucrative growth avenues for the transdermal drug delivery system market in the future. Some advantageous features like non-invasiveness, lower pain sensations in patients, and ease of treatment termination are also driving this market. However, these drug delivery systems have various disadvantages like irritation at the application site and edema, which may impede this global market.
The transdermal drug delivery system market is fragmented based on type, application, and end-user. By type, the market is divided into transdermal semisolids and transdermal patches. The transdermal patches are further segmented into reservoir membrane patches, matrix patches, drug-in-adhesive patches, and microneedle patches. The transdermal semisolids further include sprays, ointments, and gels. Transdermal patches accounted for the largest share in the global market in 2018, due to their several benefits like decreased dosing frequency, enhanced bioavailability, and ability of drug termination at any stage by simply removing the patch.
Request for PDF Brochure of This Report: https://www.zionmarketresearch.com/requestbrochure/transdermal-drug-delivery-system-market
By application, the transdermal drug delivery system market includes cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and others. The hormonal applications segment is further classified into transdermal estrogen and testosterone replacement therapies. The pain management segment accounted for the largest share in the global market in 2018, due to the elevating burden of chronic pain globally and increasing accessibility of transdermal products for pain management.
The end-user segment of the market for transdermal drug delivery system is bifurcated into hospitals and clinics and home care settings. The home care settings segment accounted for the largest share in the global market in 2018.
Browse the full “Transdermal Drug Delivery System Market By Type (Transdermal Patches and Transdermal Semisolids), By Application (Pain Management, Hormonal Applications, Central Nervous System Disorders, Cardiovascular Diseases, and Others), and By End-User (Home Care Settings and Hospitals & Clinics): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”Report at https://www.zionmarketresearch.com/report/transdermal-drug-delivery-system-market
North America accounted for the largest share in the global transdermal drug delivery system market in 2018 and is anticipated to remain dominant over the forecast time period as well. The rising incidences of chronic diseases and growing aging population are major contributing factors of this regional market. According to the CDC, one in every three Americans has high blood pressure. Moreover, only 54% of individuals with elevated BP are in control of their situation. Furthermore, the increasing use of contraceptives and the growing number of transdermal drug delivery systems study operations will also propel this regional market over the forecast time period.
Europe accounted for the second position in terms of market share in the global transdermal drug delivery system market in 2018. In 2007, the first commercially accessible vapor patch to decrease smoking practices was endorsed in Europe. Transdermal patches are gaining a market worldwide for transdermal drug delivery, as physicians and patients are placing greater emphasis on simple drug delivery techniques.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/transdermal-drug-delivery-system-market
The Asia pacific transdermal drug delivery system market is expected to register the highest growth rate globally in the future. India and China accounted for the largest shares in the Asia pacific transdermal drug delivery system market in 2018 and are expected to register the highest CAGR over the forecast time period. The large population base in China and India and a huge patient pool of chronic disease are contributing toward these countries’ market growth. Moreover, rising healthcare expenditure, growing healthcare awareness, and rising investments by various players operating in the region for the development of newer transdermal drug delivery system technology are also boosting this regional market.
Latin America and the Middle East and Africa accounted for least shares in the transdermal drug delivery system market globally, due to less regional awareness about newer technologies and low affordability rate.
Some key players in the transdermal drug delivery system market are GlaxoSmithKline, Novartis, Johnson & Johnson, Endo International, Purdue Pharma, Boehringer Ingelheim, Hisamitsu Pharmaceutical, Bristol-Myers Squibb, Mylan, and Bayer.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/3835
This report segments the global transdermal drug delivery system market into:
Global Transdermal Drug Delivery System Market: Type Analysis
- Transdermal Patches
- Drug-In-Adhesive Patches
- Matrix Patches
- Reservoir Membrane Patches
- Microneedle Patches
- Transdermal Semisolids
Global Transdermal Drug Delivery System Market: Application Analysis
- Pain Management
- Hormonal Applications
- Testosterone Replacement Therapy
- Transdermal Estrogen Therapy
- Central Nervous System Disorders
- Cardiovascular Diseases
- Other Applications
Global Transdermal Drug Delivery System Market: End-User Analysis
- Hospitals and Clinics
- Home Care Settings
Global Transdermal Drug Delivery System Market: Regional Analysis
- North America
- The U.S.
- Asia Pacific
- Latin America
- The Middle East and Africa
- Pediatric Vaccine Market: https://www.zionmarketresearch.com/report/pediatric-vaccine-market
- Peptide and Anticoagulant Drugs Market: https://www.zionmarketresearch.com/report/peptide-anticoagulant-drugs-market
- Intravenous Immunoglobulin Market: https://www.zionmarketresearch.com/report/intravenous-immunoglobulin-ivig-market
- Generic Oncology Drugs Market: https://www.zionmarketresearch.com/report/generic-oncology-drugs-market
- Opioid Tolerance Treatment Market: https://www.zionmarketresearch.com/report/opioid-tolerance-treatment-market
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Visit Our Blog: http://zmrnewsnetwork.com
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651